Erman Akkus and Omer Dizdar
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Erman Akkus, Medical Oncology fellow at Ankara University, Faculty of Medicine, shared a post on X:
“Negative hyper-selection for anti-EGFR therapy in mCRC.
- Mutations other than RAS may be a resistant cause for anti-EGFR.
- Professor Dr. Omer Dizdar discuss targeted strategies in mCRC.”
Erman Akkus is a medical oncology fellow at Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 07:13
Apr 19, 2025, 06:30
Apr 19, 2025, 06:20
Apr 19, 2025, 06:10
Apr 19, 2025, 05:31
Apr 19, 2025, 03:00